CHK-31325-13688
2 vaccinations
8 coded responses
11 check-ins
8 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 007 / PR
- Registered
- 2022-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-12-15
Dose 1 — Pfizer-BioNTech
-
2022-01-11
Dose 2 — Pfizer-BioNTech
-
2022-01-12
Registered in v-safe
-
2022-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Dysuria, Nasal flaring, Pyrexia, Respiratory disorder, Unevaluable event — Feeling: Poor · Site: Pain · Fever · Get care from a doctor or other healthcare professional · HospitalizationFree text: Systemic reaction (other): Fever, dysuria, Respiratory Difficulty, Retractions and Nasal Flaring · Healthcare visit (other): Respiratory Treatment q2hrs, IV abd inhaled steroids, IV AntibioticsMedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
-
2022-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea, Hospitalisation, Respiratory therapy, Unevaluable event — Feeling: Poor · Site: Pain · Get care from a doctor or other healthcare professional · HospitalizationFree text: Systemic reaction (other): Still difficulty breathing, dysutia · Healthcare visit (other): Still hospitalized with oxigen, respiratory treatment, IN and inhaled steroidsMedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-01-13
-
2022-01-13
Callback requested for05:30PM ET
-
2022-01-13
Call successfulCompleted over the phone
-
2022-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Hospitalisation — Feeling: Fair · Site: Pain · Fatigue or tiredness · Get care from a doctor or other healthcare professionalFree text: Released today from hospitalMedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Report sent to call center — days 1–6 daily, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2022-01-14
Call successfulReported to VAERS during previous contact from GDIT
-
2022-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Respiratory disorder — Feeling: Fair · Site: Pain · Be unable to do your normal daily activitiesFree text: Impring breathingMedDRA releases: 2024-11 · check-in free text available
-
2022-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Respiratory symptom — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Improving cough and respiratory symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-18
Call successfulReported to VAERS during previous contact from GDIT
-
2022-01-20
Health check-in — day 7, dose 2Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-13
Survey response — day 28, dose 2MedDRA: Amenorrhoea — Feeling: FairFree text: No periodMedDRA releases: 2024-11 · check-in free text available
- 2022-02-17
-
2022-02-24
Survey response — day 42, dose 2MedDRA: Hypersensitivity, Menstruation delayed, Urticaria — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Delayed in period, hives, allergic reactionsMedDRA releases: 2024-11 · check-in free text available
-
2022-02-24
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-28
-
2022-04-12
Survey response — 3 months, dose 2MedDRA: Menstrual disorder, Menstruation irregular — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Abnormal bleeding, black like, almost constant petiodsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-12
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-19
Call successfulReported to VAERS during previous contact from GDIT
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-15 | Pfizer-BioNTech | No |
| 2 | 2022-01-11 | Pfizer-BioNTech | No |
Call center
5 call center cases
5 successful
VAERS report filed, before or during a call: 5
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Fever, dysuria, Respiratory Difficulty, Retractions and Nasal Flaring
Healthcare visit (other): Respiratory Treatment q2hrs, IV abd inhaled steroids, IV Antibiotics
Systemic reaction (other): Still difficulty breathing, dysutia
Healthcare visit (other): Still hospitalized with oxigen, respiratory treatment, IN and inhaled steroids
Healthcare visit (other): Released today from hospital
Systemic reaction (other): Impring breathing
Systemic reaction (other): Improving cough and respiratory symptoms
Release 11 — day 28, dose 2
Symptoms: No period
Release 11 — day 42, dose 2
Symptoms: Delayed in period, hives, allergic reactions
Release 11 — 3 months, dose 2
Symptoms: Abnormal bleeding, black like, almost constant petiods
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Hospitalisation | · | · | ✓ |
| HCVO | Respiratory therapy | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Amenorrhoea | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Menstrual disorder | · | · | ✓ |
| SD | Menstruation delayed | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Urticaria | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Dysuria | · | · | ✓ |
| SRO | Nasal flaring | · | · | ✓ |
| SRO | Pyrexia | · | · | ✓ |
| SRO | Respiratory disorder | · | · | ✓ |
| SRO | Respiratory symptom | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release